LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion

Apichat Kaewdech (Songkla, Thailand), Apichat Kaewdech, Warangkana Keeratichananont

Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Session: Malignant pleural disease: diagnosis and management
Session type: Poster Discussion
Number: 3398
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Apichat Kaewdech (Songkla, Thailand), Apichat Kaewdech, Warangkana Keeratichananont. LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion. Eur Respir J 2016; 48: Suppl. 60, 3398

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Pleurodesis success rate for malignant pleural effusions - talc slurry vs. poudrage
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015

Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Iodopovidone pleurodesis in malignant pleural effusion: Is tube clamping time affected the efficacy & safety?
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013

Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



LATE-BREAKING ABSTRACT: Cytoreduction surgery and hypertermic intraoperative intrapleural chemotherapy for malignant pleural diseases: initial experience
Source: International Congress 2014 – Risk assessment and tracheal reconstructions
Year: 2014



A novel pleural-bladder pump for management of pleural effusion
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Utility of sending pleural fluid for cytology at the time of thoracoscopy and pleural biopsy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Tunneled indwelling pleural catheter (TPC) in recurrent malignant pleural effusions: A retrospective study of 230 patients
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013